News Release
Maruho Announces Executive Personnel Changes and New Executive Structure
Osaka (Japan), December 21, 2020 - Maruho Co., Ltd ("Maruho", Head Office: Osaka, Japan) announces that as of December 18, 2020, Representative Directors, Board of Directors and Corporate Officers have been changed, in addition to a new executive structure as stated below.
<Executive Personnel Changes>
Representative Directors
Name | New Title | Previous Title |
Koichi Takagi | Representative Director, Chairman of the Board |
Representative Director, President & CEO |
Atsushi Sugita | Representative Director, President & CEO |
Director of the Board, Executive Vice President |
Profile of Representative Director, President & CEO
March, 2012 | Entered Company |
October, 2013 | Associate General Manager, Global Business Development Dept. |
October, 2014 | Corporate Officer, North American Region |
December, 2014 | Director of the Board, Corporate Officer, North American Region |
January, 2016 |
Director of the Board, Corporate Officer, Corporate Planning, Global Business Management |
December, 2016 | Director of the Board, Senior Corporate Officer, Global Strategy & Business Development, Finance & Accounting, Human Resources |
October, 2018 | Director of the Board, Executive Corporate Officer, Business Operations & Administration |
January, 2020 | Director of the Board, Executive Vice President |
December, 2020 | Representative Director, President & CEO(Current) |
Atsushi Sugita
Birthdate: | June 24, 1974 (46 years old) |
Birthplace: | Osaka Prefecture |
Academic Background: | Graduated from Faculty of Economics, Kyoto University Master's degree from Kellogg School of Management, Northwestern University |
<New Executive Structure>
1.Board of Directors and Auditors
Representative Director, Chairman of the Board | Koichi Takagi |
Representative Director, President & CEO | Atsushi Sugita |
Director of the Board | Yasuyuki Ishimaru |
Director of the Board | Yasuhiko Kito |
Director of the Board | Masahiro Takeda |
Director of the Board | Takashi Kitagawa (New) |
Director of the Board | Junichi Hamada (New) |
Director of the Board (Outside) | Akihiro Watanabe |
Director of the Board (Outside) | Yoshihiko Akagi |
Director of the Board (Outside) | Toshio Asano |
Corporate Audit & Supervision | Hiroaki Miura |
*As of December 18, 2020, Director of the Board Tetsuto Takaki was appointed as an advisor.
2.Corporate Officers
President & CEO | Atsushi Sugita |
Executive Corporate Officer | Yasuyuki Ishimaru |
Senior Corporate Officers | |
Global Business Development & Drug Discovery Research | Junichi Hamada |
Research & Development, Reliability Assurance & Medical Affairs | Yasuhiko Kito |
Japan Business Operations | Takashi Kitagawa |
Corporate Planning, Business Operations, CMC Research & Production | Masahiro Takeda |
Corporate Officers | |
General Manager, Drug Discovery Research Department | Kazumasa Hirata |
Research & Development | Yutaka Ishihama |
Reliability Assurance & Medical Affairs | Yoshimi Kakiuchi |
Sales | Yoshihiko Sato |
Business Operations | Koichi Nishioka |
Production | Katsunori Hiratsuka |